Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Hachimijiogan and Ryutan-shakan in Lower Urinary Tract Symptom Patients with Benign Prostatic Hyperplasia
KCT0004112Phase 4Not yet recruiting
- Sponsor
- Korea Institute of Oriental Medicine
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hachimijiogan in benign prostatic hyperplasia (BPH), sponsored by Korea Institute of Oriental Medicine. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
hachimijiogan
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on KCT0004112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004112.